Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Exploring the role of mitochondrial proteins as molecular target in Alzheimer's disease

Chadha S, Behl T, Sehgal A, Kumar A, Bungau S.

Mitochondrion. 2021 Jan;56:62-72. doi: 10.1016/j.mito.2020.11.008. Epub 2020 Nov 19.

ABCA7 links sterol metabolism to the host defense system: Molecular background for potential management measure of Alzheimer's disease

Abe-Dohmae S, Yokoyama S.

Gene. 2021 Feb 5;768:145316. doi: 10.1016/j.gene.2020.145316. Epub 2020 Nov 20.

What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?

Wimo A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):1-4. doi: 10.1080/14737167.2021.1848551. Epub 2020 Nov 26.

Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease

Salminen A.

Neurochem Int. 2021 Jan;142:104919. doi: 10.1016/j.neuint.2020.104919. Epub 2020 Nov 23.

Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1

Peak SL, Gracia L, Lora G, Jinwal UK.

Neuroscience. 2021 Jan 15;453:312-323. doi: 10.1016/j.neuroscience.2020.11.020. Epub 2020 Nov 24.

The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology

Doifode T, Giridharan VV, Generoso JS, Bhatti G, Collodel A, Schulz PE, Forlenza OV, Barichello T.

Pharmacol Res. 2021 Feb;164:105314. doi: 10.1016/j.phrs.2020.105314. Epub 2020 Nov 25.

Mini-review: Role of the PI3K/Akt pathway and tyrosine phosphatases in Alzheimer's disease susceptibility

Curtis D, Bandyopadhyay S.

Ann Hum Genet. 2021 Jan;85(1):1-6. doi: 10.1111/ahg.12410. Epub 2020 Dec 1.

Spatial Distribution of Tau and β-Amyloid Pathologies and Their Role in Different Alzheimer Disease Phenotypes

Palmqvist S, Eshaghi A.

Neurology. 2021 Feb 2;96(5):191-192. doi: 10.1212/WNL.0000000000011272. Epub 2020 Dec 1.

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease

Zhang F, Zhong RJ, Cheng C, Li S, Le WD.

Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.

Insight into the roles of CCR5 in learning and memory in normal and disordered states

Necula D, Riviere-Cazaux C, Shen Y, Zhou M.

Brain Behav Immun. 2021 Feb;92:1-9. doi: 10.1016/j.bbi.2020.11.037. Epub 2020 Dec 1.

Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation

Ashrafian H, Zadeh EH, Khan RH.

Int J Biol Macromol. 2021 Jan 15;167:382-394. doi: 10.1016/j.ijbiomac.2020.11.192. Epub 2020 Dec 2.

The association between toxic pesticide environmental exposure and Alzheimer's disease: A scientometric and visualization analysis

Li Y, Fang R, Liu Z, Jiang L, Zhang J, Li H, Liu C, Li F.

Chemosphere. 2021 Jan;263:128238. doi: 10.1016/j.chemosphere.2020.128238. Epub 2020 Sep 4.

Role of reactive oxygen species in the progression of Alzheimer's disease

Bhatt S, Puli L, Patil CR.

Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.

AMPK: A bridge between diabetes mellitus and Alzheimer's disease

Chen M, Huang N, Liu J, Huang J, Shi J, Jin F.

Behav Brain Res. 2021 Feb 26;400:113043. doi: 10.1016/j.bbr.2020.113043. Epub 2020 Dec 8.

Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?

Voronkov M, Cocchiaro B, Stock JB.

Neurochem Int. 2021 Feb;143:104936. doi: 10.1016/j.neuint.2020.104936. Epub 2020 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias